These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 27225268)
1. Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series. Noma H; Yasuda K; Minezaki T; Watarai S; Shimura M BMC Ophthalmol; 2016 May; 16():61. PubMed ID: 27225268 [TBL] [Abstract][Full Text] [Related]
2. Retinal blood flow levels measured by laser speckle flowgraphy in patients who received intravitreal bevacizumab injection for macular edema secondary to central retinal vein occlusion. Matsumoto M; Suzuma K; Fukazawa Y; Yamada Y; Tsuiki E; Fujikawa A; Kitaoka T Retin Cases Brief Rep; 2014; 8(1):60-6. PubMed ID: 25372211 [TBL] [Abstract][Full Text] [Related]
3. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab. Nagaoka T; Sogawa K; Yoshida A Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136 [TBL] [Abstract][Full Text] [Related]
4. Changes in Retinal Microcirculation After Intravitreal Ranibizumab Injection in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion. Fukami M; Iwase T; Yamamoto K; Kaneko H; Yasuda S; Terasaki H Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1246-1255. PubMed ID: 28241312 [TBL] [Abstract][Full Text] [Related]
5. Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema. Yasuda K; Noma H; Mimura T; Nonaka R; Sasaki S; Suganuma N; Shimura M Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374257 [No Abstract] [Full Text] [Related]
6. Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion. Terui T; Kondo M; Sugita T; Ito Y; Kondo N; Ota I; Miyake K; Terasaki H Retina; 2011 Jun; 31(6):1068-74. PubMed ID: 21451440 [TBL] [Abstract][Full Text] [Related]
7. POSSIBLE MOLECULAR BASIS OF BEVACIZUMAB THERAPY FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION. Noma H; Mimura T; Yasuda K; Shimura M Retina; 2016 Sep; 36(9):1718-25. PubMed ID: 26866529 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions. Tomomatsu Y; Tomomatsu T; Takamura Y; Gozawa M; Arimura S; Takihara Y; Inatani M Acta Ophthalmol; 2016 May; 94(3):e225-30. PubMed ID: 25989706 [TBL] [Abstract][Full Text] [Related]
9. RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION. Matsumoto M; Suzuma K; Yamada Y; Tsuiki E; Fujikawa A; Kitaoka T Retina; 2018 Feb; 38(2):283-291. PubMed ID: 28151838 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal Bevacizumab (IVB) for Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO). Azhar MN; Muzaffar W; Arain MA; Farooq O J Coll Physicians Surg Pak; 2018 Oct; 28(10):758-761. PubMed ID: 30266119 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion. Yang CS; Liu JH; Chung YC; Chou YB; Hung KH J Ocul Pharmacol Ther; 2015 Apr; 31(3):179-85. PubMed ID: 25715024 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion. Moon J; Kim M; Sagong M Eye (Lond); 2016 Aug; 30(8):1084-90. PubMed ID: 27229707 [TBL] [Abstract][Full Text] [Related]
13. Importance of Central Retinal Sensitivity for Prediction of Visual Acuity after Intravitreal Bevacizumb in Eyes with Macular Edema Associated with Branch Retinal Vein Occlusion. Sugimoto M; Ichio A; Kondo M PLoS One; 2016; 11(2):e0149246. PubMed ID: 26885822 [TBL] [Abstract][Full Text] [Related]
14. Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion. Noma H; Yasuda K; Mimura T; Suganuma N; Shimura M J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33375281 [TBL] [Abstract][Full Text] [Related]
15. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema. Noma H; Mimura T; Yasuda K; Shimura M Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159 [TBL] [Abstract][Full Text] [Related]
16. Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection. Yoo JH; Ahn J; Oh J; Cha J; Kim SW Br J Ophthalmol; 2017 Oct; 101(10):1334-1339. PubMed ID: 28232381 [TBL] [Abstract][Full Text] [Related]
17. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion. Kwon SI; Kim YW; Bang YW; Lee JY; Park IW J Ocul Pharmacol Ther; 2013 Feb; 29(1):5-9. PubMed ID: 23237542 [TBL] [Abstract][Full Text] [Related]
18. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
19. Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion. Sacu S; Pemp B; Weigert G; Matt G; Garhofer G; Pruente C; Schmetterer L; Schmidt-Erfurth U Invest Ophthalmol Vis Sci; 2011 May; 52(6):3046-50. PubMed ID: 21051706 [TBL] [Abstract][Full Text] [Related]
20. Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels. Im JC; Shin JP; Kim IT; Park DH Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1267-74. PubMed ID: 26383643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]